Search
The DNA breaks that occur during meiosis are necessary but dangerous. Scientists now have a better handle on how cells control the chaos.
Meet molecular biologist Agnel Sfeir, who joined SKI's Molecular Biology Program in March 2021.
The 2016 GSK Experimental Therapeutics Symposium will be held at MSKCC this fall in continuation of the former Med into Grad Program.
Learn how GSK graduate Dr. Ellen Horste’s time investigating fundamental biological questions prepared her for a career in the emerging field of gene therapy.
An international, multi-center study has revealed the discovery of a novel oncogene that is associated with uveal melanoma, the most common form of eye cancer. Researchers have isolated an oncogene called GNA11 and have found that it is present in more than 40 percent of tumor samples taken from patients with uveal melanoma.
DNA in the mitochondria of cancer cells may yield insights that lead to more accurate prognoses and new treatment strategies.
Gregory Mazo has been awarded the Chairman’s Prize for his first-author paper Spatial Control of Primary Ciliogenesis by Subdistal Appendages Alters Sensation-Associated Properties of Cilia, published in Developmental Cell in 2016.
Learn more about the work of MSK researchers being presented at the 2018 meeting of the American Society of Hematology.
When an immune cell faces a foe, it has more than chemical weapons at its disposal.
Sloan Kettering Institute investigators have found that a subpopulation of cells within a type of sarcoma called malignant peripheral nerve sheath tumor appear to be similar to a type of neural stem cells.